Pages that link to "Q30728924"
Jump to navigation
Jump to search
The following pages link to Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells (Q30728924):
Displaying 50 items.
- Mechanisms of cellular uptake of cell-penetrating peptides (Q21296784) (← links)
- Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides (Q24793327) (← links)
- A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits (Q27301045) (← links)
- Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. (Q30489569) (← links)
- Determination of penetratin secondary structure in live cells with Raman microscopy (Q30493051) (← links)
- How to address CPP and AMP translocation? Methods to detect and quantify peptide internalization in vitro and in vivo (Review). (Q33285497) (← links)
- Intracellular delivery of peptides via association with ubiquitin or SUMO-1 coupled to protein transduction domains (Q33321966) (← links)
- Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos (Q33327293) (← links)
- Tumor imaging by means of proteolytic activation of cell-penetrating peptides (Q33569121) (← links)
- Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines (Q33732116) (← links)
- Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides (Q33754501) (← links)
- Dominant-negative regulation of cell surface expression by a pentapeptide motif at the extreme COOH terminus of an Slo1 calcium-activated potassium channel splice variant (Q33754862) (← links)
- Enhancement of Intracellular Delivery of Anti-cancer Drugs by the Tat Peptide (Q33846530) (← links)
- Relationships between membrane binding, affinity and cell internalization efficacy of a cell-penetrating peptide: penetratin as a case study. (Q34018908) (← links)
- Effects of chirality on the intracellular localization of binuclear ruthenium(II) polypyridyl complexes (Q34152263) (← links)
- Cyclic peptide-selenium nanoparticles as drug transporters. (Q34293631) (← links)
- Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission (Q34419039) (← links)
- Characterization of a novel cell penetrating peptide derived from human Oct4. (Q34504889) (← links)
- Cell surface binding and internalization of aβ modulated by degree of aggregation (Q34572746) (← links)
- Characterisation of cell-penetrating peptide-mediated peptide delivery (Q35049077) (← links)
- The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells (Q35684572) (← links)
- Cancer cell surface induced peptide folding allows intracellular translocation of drug (Q35691164) (← links)
- Aminopeptidase P Mediated Targeting for Breast Tissue Specific Conjugate Delivery. (Q35953315) (← links)
- Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides (Q36299512) (← links)
- Free energy of translocating an arginine-rich cell-penetrating peptide across a lipid bilayer suggests pore formation (Q36554270) (← links)
- Cell-penetrating peptides and antimicrobial peptides: how different are they? (Q36586917) (← links)
- The taming of the cell penetrating domain of the HIV Tat: myths and realities (Q36695464) (← links)
- Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives (Q36795351) (← links)
- Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine (Q36841273) (← links)
- Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides (Q36924383) (← links)
- Bioconjugation of oligonucleotides for treating liver fibrosis (Q37043515) (← links)
- The design of guanidinium-rich transporters and their internalization mechanisms. (Q37047226) (← links)
- Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics (Q37230918) (← links)
- Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters (Q37262485) (← links)
- Prospects for antisense peptide nucleic acid (PNA) therapies for HIV (Q37473797) (← links)
- Exploring Transduction Mechanisms of Protein Transduction Domains (PTDs) in Living Cells Utilizing Single-Quantum Dot Tracking (SQT) Technology (Q37988482) (← links)
- New views on cellular uptake and trafficking of manufactured nanoparticles. (Q38083258) (← links)
- Elastin-like recombinamers with acquired functionalities for gene-delivery applications. (Q38898870) (← links)
- Altering the Tat-derived peptide bioactivity landscape by changing the arginine side chain length. (Q39310299) (← links)
- Cell‐Penetrating Homochiral Cyclic Peptides as Nuclear‐Targeting Molecular Transporters (Q39473535) (← links)
- De Novo Designed Protein Transduction Domain Mimics from Simple Synthetic Polymers (Q39516013) (← links)
- Calcium Condensation of DNA Complexed with Cell-Penetrating Peptides Offers Efficient, Noncytotoxic Gene Delivery (Q39581513) (← links)
- Design of aromatic-containing cell-penetrating peptide mimics with structurally modified π electronics (Q39658916) (← links)
- "Soft" calcium crosslinks enable highly efficient gene transfection using TAT peptide (Q39793490) (← links)
- The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides (Q39807870) (← links)
- Low concentration thresholds of plasma membranes for rapid energy-independent translocation of a cell-penetrating peptide (Q39884008) (← links)
- Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells (Q40023049) (← links)
- Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34 leukaemia cells. (Q40184296) (← links)
- Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide. (Q40199589) (← links)
- Penetratin-membrane association: W48/R52/W56 shield the peptide from the aqueous phase. (Q40317625) (← links)